We are experts in oral, nasal and pulmonary delivery – able to support you to Phase I quickly or help you transition into Phase II and scale up to Phase III.
Meet our Executive Leaders at CPHI Frankfurt to discover more about how we can bring success to your drug development journey.
Discover more about our integrated CDMO services and expertise in oral, nasal and pulmonary dosage forms.
Meet our experts
Dr. Ian Lafferty
Chief Technical Officer
Laura Mason
Director of Pharmaceutical Sciences
Paul Kelsall
Director of Clinical Manufacturing
Michael Mellor-Clark
Chief Commercial Officer
Request a meeting
Connect with our experts at DCAT Week and request a meeting to learn more about our integrated CDMO services.
